Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Banatwala
N
N
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004733:Enema; D005260:Female; D005492:Folic Acid / Q000378:metabolism; D005944:Glucosamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D019804:Mesalamine; D011247:Pregnancy; D013427:Sulfapyridine / Q000009:adverse effects; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000636:Aminosalicylic Acids; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D019804:Mesalamine; D005492:Folic Acid; D005944:Glucosamine; D013427:Sulfapyridine